IL160299A0 - Sodium channel regulators and modulators - Google Patents

Sodium channel regulators and modulators

Info

Publication number
IL160299A0
IL160299A0 IL16029902A IL16029902A IL160299A0 IL 160299 A0 IL160299 A0 IL 160299A0 IL 16029902 A IL16029902 A IL 16029902A IL 16029902 A IL16029902 A IL 16029902A IL 160299 A0 IL160299 A0 IL 160299A0
Authority
IL
Israel
Prior art keywords
modulators
sodium channel
channel regulators
regulators
sodium
Prior art date
Application number
IL16029902A
Other languages
English (en)
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of IL160299A0 publication Critical patent/IL160299A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16029902A 2001-08-20 2002-08-20 Sodium channel regulators and modulators IL160299A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120238.1A GB0120238D0 (en) 2001-08-20 2001-08-20 Sodium channel regulators and modulators
PCT/GB2002/003852 WO2003016917A2 (en) 2001-08-20 2002-08-20 Sodium channel regulators and modulators

Publications (1)

Publication Number Publication Date
IL160299A0 true IL160299A0 (en) 2004-07-25

Family

ID=9920687

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16029902A IL160299A0 (en) 2001-08-20 2002-08-20 Sodium channel regulators and modulators

Country Status (9)

Country Link
US (1) US7563586B2 (ja)
EP (1) EP1421391A2 (ja)
JP (1) JP2005500843A (ja)
AU (1) AU2002355997B2 (ja)
CA (1) CA2457932A1 (ja)
GB (2) GB0120238D0 (ja)
IL (1) IL160299A0 (ja)
NO (1) NO20040715L (ja)
WO (1) WO2003016917A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211833D0 (en) * 2002-05-22 2002-07-03 Univ London Sodium channel regulators and modulators
WO2004087956A2 (en) * 2003-04-02 2004-10-14 Ionix Pharmaceuticals Limited Cell lines for the functional expression of nav1.8
US8006176B2 (en) * 2004-10-08 2011-08-23 Sharp Laboratories Of America, Inc. Methods and systems for imaging-device-based form field management
JP2008517629A (ja) * 2004-10-27 2008-05-29 シェーリング コーポレイション Ｎａｖ１．８の短い干渉核酸阻害のための組成物および方法
US20070082409A1 (en) * 2005-09-15 2007-04-12 The Regents Of The University Of Michigan Method and apparatus for measuring cartilage condition biomarkers
US7972813B2 (en) * 2005-09-30 2011-07-05 Vertex Pharmaceuticals Incorporated Tetrodotoxin-resistant sodium channel alpha subunit
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
CA2704786C (en) * 2007-11-02 2019-04-09 Cornell University Materials and methods for gene mediated therapy of psychiatric disorders
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
PL2580240T4 (pl) 2010-06-14 2020-03-31 Lykera Biomed S.A. Przeciwciała s100a4 i ich terapeutyczne zastosowania
US9340590B2 (en) 2011-03-16 2016-05-17 Amgen Inc. Potent and selective inhibitors of NaV1.3 and NaV1.7
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
US9636418B2 (en) 2013-03-12 2017-05-02 Amgen Inc. Potent and selective inhibitors of NAV1.7
CN104177479B (zh) * 2013-05-22 2016-12-28 中国人民解放军国防科学技术大学 一种多肽及其在制备电压敏感钠通道抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616500A (en) * 1993-04-30 1997-04-01 The United States Of America As Represented By The Department Of Health & Human Services Trichohyalin and transglutaminase-3 and methods of using same
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
GB9513180D0 (en) * 1995-06-28 1995-08-30 Univ London Ion channel
US6184349B1 (en) * 1995-10-11 2001-02-06 Syntex (Usa) Inc. Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit
US5892018A (en) * 1996-04-02 1999-04-06 Welsh; Michael J. DNA sequences encoding a brain sodium channel protein
EP1140137A2 (en) * 1998-12-18 2001-10-10 Scios Inc. Method for detection and use of differentially expressed genes in disease states
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels

Also Published As

Publication number Publication date
AU2002355997B2 (en) 2008-01-31
GB2387906B (en) 2004-05-26
NO20040715L (no) 2004-05-06
WO2003016917A3 (en) 2003-05-30
EP1421391A2 (en) 2004-05-26
WO2003016917A2 (en) 2003-02-27
JP2005500843A (ja) 2005-01-13
CA2457932A1 (en) 2003-02-27
GB0120238D0 (en) 2001-10-10
US20040248207A1 (en) 2004-12-09
GB2387906A (en) 2003-10-29
US7563586B2 (en) 2009-07-21
GB0317959D0 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AU2002361359A8 (en) Remouvable eyewear member
AU2001286965A1 (en) Sodium channel modulators
AU2002236775A1 (en) Sodium channel modulators
GB2387906B (en) Sodium channel regulators and modulators
GB2382109B (en) Seal member
GB0123379D0 (en) Modulators
GB0020532D0 (en) Channel member
GB0116965D0 (en) Cosmetic devices
EP1430125A4 (en) SPERM-SPECIFIC CATIONIC CHANNEL, AND USES THEREOF
GB2389654B (en) Sodium channel regulators and modulators
GB0126318D0 (en) Sealing member
GB0115567D0 (en) Face mask
EP1448589A4 (en) THE SPERM SPECIFIC CATION CHANNEL CATSPER2 AND USES THEREOF
GB0103289D0 (en) Control and communication methods
AU2002358719A1 (en) Agaricoglycerides and analogs
HUP0600032A2 (en) Sodium channel modulators derived from 2-piperidylimidazoles
GB0118416D0 (en) Desulphurisation
GB0130048D0 (en) Pressure regulating device
GB2372577B (en) Electro-optic modulator
GB0115363D0 (en) Ion channel modulators
GB0106338D0 (en) Electro-optic modulators
GB2374107B (en) Channel sections
GB0200803D0 (en) Application guide
AU150772S (en) Channel
TW524307U (en) Standard line fixing and adjusting structure